Cargando…
Celiac disease in the COVID-19 pandemic
BACKGROUND: The COVID-19 pandemic has had an impact on global health. DESIGN: The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review. RESULTS: The incidence of coeliac disease and the problems associated with coeliac disease increased during the COVID...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406545/ https://www.ncbi.nlm.nih.gov/pubmed/34485888 http://dx.doi.org/10.1016/j.jtauto.2021.100120 |
_version_ | 1783746524170158080 |
---|---|
author | Samasca, Gabriel Lerner, Aaron |
author_facet | Samasca, Gabriel Lerner, Aaron |
author_sort | Samasca, Gabriel |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic has had an impact on global health. DESIGN: The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review. RESULTS: The incidence of coeliac disease and the problems associated with coeliac disease increased during the COVID-19 pandemic. Adherence to the diet is crucial for the patient's health and quality of life since the only approved therapy for coeliac disease is a gluten withdrawal. CONCLUSIONS: A gluten-free diet should be promoted by the therapeutic team and implemented among these categories of patients. |
format | Online Article Text |
id | pubmed-8406545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84065452021-08-31 Celiac disease in the COVID-19 pandemic Samasca, Gabriel Lerner, Aaron J Transl Autoimmun VSI: Autoimmune tautology, Infection and autoimmunity BACKGROUND: The COVID-19 pandemic has had an impact on global health. DESIGN: The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review. RESULTS: The incidence of coeliac disease and the problems associated with coeliac disease increased during the COVID-19 pandemic. Adherence to the diet is crucial for the patient's health and quality of life since the only approved therapy for coeliac disease is a gluten withdrawal. CONCLUSIONS: A gluten-free diet should be promoted by the therapeutic team and implemented among these categories of patients. Elsevier 2021-08-31 /pmc/articles/PMC8406545/ /pubmed/34485888 http://dx.doi.org/10.1016/j.jtauto.2021.100120 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | VSI: Autoimmune tautology, Infection and autoimmunity Samasca, Gabriel Lerner, Aaron Celiac disease in the COVID-19 pandemic |
title | Celiac disease in the COVID-19 pandemic |
title_full | Celiac disease in the COVID-19 pandemic |
title_fullStr | Celiac disease in the COVID-19 pandemic |
title_full_unstemmed | Celiac disease in the COVID-19 pandemic |
title_short | Celiac disease in the COVID-19 pandemic |
title_sort | celiac disease in the covid-19 pandemic |
topic | VSI: Autoimmune tautology, Infection and autoimmunity |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406545/ https://www.ncbi.nlm.nih.gov/pubmed/34485888 http://dx.doi.org/10.1016/j.jtauto.2021.100120 |
work_keys_str_mv | AT samascagabriel celiacdiseaseinthecovid19pandemic AT lerneraaron celiacdiseaseinthecovid19pandemic |